Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1970 1
1984 1
1989 1
1999 1
2003 1
2006 4
2007 12
2008 19
2009 16
2010 6
2011 8
2012 2
2013 9
2014 4
2015 3
2016 4
2017 4
2018 1
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 19952299

92 results
Results by year
Filters applied: . Clear all
Page 1
Incretin-based therapies for type 2 diabetes mellitus: New therapeutic mechanisms.
Kennedy L. Kennedy L. Cleve Clin J Med. 2009 Dec;76 Suppl 5:S2-3. doi: 10.3949/ccjm.76.s5.01. Cleve Clin J Med. 2009. PMID: 19952299 Free article. Review. No abstract available.
Clinical and economic implications of incretin-based therapies.
Briggs GC. Briggs GC. Endocrinol Metab Clin North Am. 2007 Dec;36 Suppl 2 Incretin:18-26. Endocrinol Metab Clin North Am. 2007. PMID: 18405145 Review. No abstract available.
New treatments in type 2 diabetes: a focus on the incretin-based therapies.
Barnett AH. Barnett AH. Clin Endocrinol (Oxf). 2009 Mar;70(3):343-53. doi: 10.1111/j.1365-2265.2008.03396.x. Epub 2008 Sep 2. Clin Endocrinol (Oxf). 2009. PMID: 18771570 Review.
Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
Inzucchi SE. Inzucchi SE. Endocrinol Metab Clin North Am. 2007 Dec;36 Suppl 2 Incretin:2-17. Endocrinol Metab Clin North Am. 2007. PMID: 18405144 Review. No abstract available.
Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.
Campbell RK. Campbell RK. Ann Pharmacother. 2007 Jan;41(1):51-60. doi: 10.1345/aph.1H459. Epub 2006 Dec 26. Ann Pharmacother. 2007. PMID: 17190843 Review.
Treating type 2 diabetes: incretin mimetics and enhancers.
Janosz KE, Zalesin KC, Miller WM, McCullough PA. Janosz KE, et al. Ther Adv Cardiovasc Dis. 2009 Oct;3(5):387-95. doi: 10.1177/1753944709341377. Ther Adv Cardiovasc Dis. 2009. PMID: 19808944 Free article. Review.
Why and when to implement incretin therapy.
Freeman JS, Unger J. Freeman JS, et al. J Fam Pract. 2008 Sep;57(9 Suppl):S19-25. J Fam Pract. 2008. PMID: 18786340 Review. No abstract available.
Treating diabetes with incretin hormones - clinical experience.
Handelsman Y. Handelsman Y. Pediatr Endocrinol Rev. 2008 Jun;5(4):897-903. Pediatr Endocrinol Rev. 2008. PMID: 18552752 Review.
Incretin based therapies for type 2 diabetes mellitus.
Ghosh S, Collier A, Elhadd T, Malik I. Ghosh S, et al. J Indian Med Assoc. 2008 Jun;106(6):373-4, 383, 388. J Indian Med Assoc. 2008. PMID: 18839649
Tapping incretin-based therapy for type 2 diabetes.
Appel SJ. Appel SJ. Nursing. 2011 Mar;41(3):49-51. doi: 10.1097/01.NURSE.0000394397.55390.75. Nursing. 2011. PMID: 21326056 No abstract available.
92 results
Jump to page
Feedback